Skip to content
Recall Observatory FDA recall evidence

Drug product

Amlodipine Besylate and Benazepril HCl Capsules, 5 mg/20 mg, packaged in a) 100-count bottles (NDC 0378-6897-01) and b) 500-count bottles (NDC 0378-6897-05), Rx only, Mylan Pharmaceuticals Inc., Morgantown, WV 26505 U.S.A.

D-66403-007

September 13, 2013

Class II

Product summary

Firm
Mylan Pharmaceuticals Inc.
Event
Event 66403
Status
Terminated
Classification
Class II
Quantity
60,506 bottles
Official record key
drug-enforcement:D-66403-007

Official wording

Reason: CGMP Deviations: Pharmaceuticals were produced and distributed with active ingredients not manufactured according to Good Manufacturing Practices.

Code information: Lot #: a) 2003169, 2003170, 2003171, 2003172, 2003173, 3043493; b) 2003168, 2003169, 3043493

Distribution pattern: Nationwide and Puerto Rico

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations